DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20212076

Bacterial infections in Indian cirrhotic patients: a prospective study

Deepak C. Gopinath, Bhat Rashmi, Sivichan Sonia, Sharon Mary Stanly, Shalumol Jose, Ranjan Amit, Nicole R. Pereira

Abstract


Background: Bacterial infections (BI) are more prevalent in liver cirrhosis (LC), high among hospitalized patients. The aim of this study was to explore the epidemiological pattern of BI in hospitalized patients with LC, and identification the causative agents. Objective of the study was evaluation of therapeutic/empirical approaches for these infections.

Methods: Inputs from the body fluid analysis and culture reports were recorded. The Child Pugh score (CPS) was used to assess the severity of liver disease. Antibiotic treatment strategy was analysed, prescribed antibiotics were checked for contraindications using Lexicomp software.

Results: Of 60 enrolled patients, four had mixed infection and 55% were culture positive. There was a male preponderance (83.3%). BI was more frequent in those aged 51-60 years (38.3%) and >60 years (35%). Higher proportion of patients (60%) belonged to class C of CPS followed by class B (31.7%). The most common causative organisms identified were E. coli (28.5%), K. pneumonia (14.2%), Enterococcus spp (11.4 %) and less common were K. oxytoca, Coagulase-negative staphylococci, Staphylococcus aureus, gram-positive cocci, gram-negative cocci, P. aeruginosa, S. hemolyticus, ß-hemolytic streptococcus spp. Majority of the subjects had spontaneous bacterial peritonitis (36.7%) followed by urinary tract infection (21%), lower respiratory tract infection (18.3%), sepsis (13.3%), cellulitis (3.3%) and acute gastroenteritis (1.7%). Cephalosporin (61.7%), rifaximin (51.7%), penicillin and β lactamase inhibitors (36.7%) were the common prescribed antimicrobials.

Conclusions: There is a positive association between the risk of BI and severity of liver damage.


Keywords


Bacterial infection, Child pugh score, Liver cirrhosis, Spontaneous bacterial peritonitis

Full Text:

PDF

References


Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol. 2014;20(10):2542-54.

Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001;33(1):41-8.

Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140-8.

Fernandez J, Acevedo J, Castro M, Garcia O, Lope CR, Roca D, Pavesi M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551-61.

Preveden T. Bacterial infections in patients with liver cirrhosis. Med Pregl. 2015;68(5):187-91.

Bajaj JS, Leary JG, Reddy KR, Wong F, Biggins SW, Patton H, Fallon MB, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60(1):250-6.

Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-37.

Allaire M, Cadranel JF, Nguyen TTN, Garioud A, Zougmore H, Heng R, et al. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review. Clin Res Hepatol Gastroenterol. 2020;44(3):264-74.

Piano S, Angeli P. Current Concepts on Bacterial and Fungal Infections in Cirrhosis. Clin Liver Dis. 2019;14(3):87-91.

Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310-24.

Lameirao GC, Violante SR, Carrola P, Presa J. Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department. GE Port J Gastroenterol. 2019;26(5):324-32.

Lagadinou M, Gogos CA. Bacterial infections in cirrhosis patients: a retrospective epidemiologic study in a greek university hospital. Clinical Hepatol and Hepatitis reports. 2015;2:1.

Yuan LT, Chuah SK, Yang SC, Liang CM, Wu CK, Tai WC, et al. Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis. PLoS One. 2018;13(5):197127.

Andreu M, Sola R, Stiges SA, Alia C, Gallen M, Vila MC, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterol. 1993;104(4):1133-8.

Amin H, Sabry AMM, Ahmed RE, Makhlouf NA. Types and microbiological spectrum of infections in patients with cirrhosis: A single-centre experience in Upper Egypt. Arab J Gastroenterol. 2017;18(3):159-64.

Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology. 2007;45(1):223-9.

Angeli P. Bacterial infections complicating Cirrhosis. Paris Hepatitis Conference, 2018. Available at: https://www.aphc.info/wpcontent/uploads/2018/01/phc-2018-def.pdf. Accessed on 11 October 2020.

Ekpanyapong S, Reddy KR. Infections in Cirrhosis. Curr Treat Options Gastroenterol. 2019;17(2):254-70.

Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, et al. Epidemiology, predictors and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Digestive and Liver Disease. 2018;50(1):2-3.

Anastasiou J, Williams R. When to use antibiotics in the cirrhotic patient? The evidence base. Ann Gastroenterol. 2013;26(2):128-31.

Ghassemi S, Garcia T G. Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21(1):77-93.

Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine. 1971;50(3)161-97.

Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012;61(2):297-310.

Zsuzsanna Vitalis, Maria Papp. In: Blackwell RM, Tyson AP. Bacterial Infections in Cirrhosis. Hungary: Nova Science Publishers; 2014: 1-26.

Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology. 2009;50(6):2022-33.

Mohan P, Ramu B, Bhaskar E, Venkataraman J. Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis. Ann Hepatol. 2011;10(1):15-20.

Nouh MA, Basha MA, Deeb GS, Masoud BM, Hammouda HA. Skin and soft tissue bacterial infections in cirrhotic patients with edema. Menoufia Med J. 2016;29(2):454-9.

Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC, et al. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. Gastroenterology. 2019;156(5):1368-80.

Cassard AM, Ciocan D. Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol. 2018;24(2):100-7.

Naqvi IH, Mahmood K, Talib A, Ubaid M, Mahmood A. Infections in Cirrhotics: Types, Microbiological Spectrum and Risk Factor- 5-Year Cohort Study. Open J of Gastroenterol. 2014;4(3):105-17.